COVID-19 (coronavirus)

Targan Lab

Personal Statement

I have been engaged in the study of inflammatory bowel disease (IBD) for four decades and have been treating patients with IBD during this time. My research interests span clinical, basic and translational research and are primarily focused on immunopathologic mechanisms, discovery of novel therapeutics and the translation of basic science and genetic findings for use in diagnosis, prognosis and targeted therapeutic selection in IBD. My goal is to combine all of these areas so that the right patient gets the right treatment at the right time and in the right way."


Stephan Targan, MD

The Targan Laboratory and other research laboratories in the F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute (IBIRI) focus primarily on the genetic and immunopathologic mechanisms of inflammatory bowel disease (IBD). Combining multiple research disciplines of IBD and translating findings for therapeutic development is a unique feature of the IBIRI laboratories under the Targan Lab umbrella.
Meet Our Team

Learn more about the scientists, faculty members, investigators and other healthcare professionals of the Targan Laboratory, whose dedicated efforts lead to groundbreaking discoveries.

Jacob N, Jacobs JP, Kumagai K, Ha CWY, Kanazawa Y, Lagishetty V, Altmayer K, Hamill AM, Von Arx A, Sartor RB, Devkota S, Braun J, Michelsen KS, Targan SR, Shih DQ. 

Muscosal Immunol. 2018 Sep;11(5):1466-1476. 

Workman MJ, Gleeson JP, Troisi EJ, Estrada HQ, Kerns SJ, Hinojosa CD, Hamilton GA, Targan SR, Svendsen CN, Barrett RJ.

Cell Mol Gastroenterol Hepatol. 2017 Dec 29;5(4):669-677.e2. 

Gonsky R, Fleshner P, Deem RL, Biener-Ramanujan E, Li D, Potdar AA, Bilsborough J, Yang S, McGovern DPB, Targan SR

Gastroenterology. 2017 Jul;153(1):219-232. 

Contact the Targan Lab

110 N. George Burns Road
Davis Building, Room D4063
Los Angeles, CA 90048